Omega-3 Study Supports Adjunct Use To Treat Major Depressive Disorder
This article was originally published in The Tan Sheet
Executive Summary
Omega-3 fatty acids may assist in the development of personalized treatment plans for major depression, as the oils were found to be especially beneficial if they contained high levels of EPA and were used by people on anti-depressants, Dutch researchers say in a meta-analysis.
You may also be interested in...
Poor Results For Supplementation To Curb Depression In First-Of-Kind Study
Supplementation with omega-3s, folic acid, vitamin D3, calcium and selenium did not reduce MDD onset in overweight subjects with history of depression, according to first RCT on effectiveness of two nutritional strategies and their combination in preventing depression among high-risk subjects.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.